- Home
- PSBD vs ORGO Comparison
PSBD vs ORGO Comparison
Compare PSBD & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSBD
- ORGO
- Stock Information
- Founded
- PSBD 2009
- ORGO 1985
- Country
- PSBD United States
- ORGO United States
- Employees
- PSBD N/A
- ORGO N/A
- Industry
- PSBD
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- PSBD
- ORGO Health Care
- Exchange
- PSBD Nasdaq
- ORGO Nasdaq
- Market Cap
- PSBD 454.8M
- ORGO 465.6M
- IPO Year
- PSBD 2024
- ORGO N/A
- Fundamental
- Price
- PSBD $14.26
- ORGO $4.32
- Analyst Decision
- PSBD Buy
- ORGO Hold
- Analyst Count
- PSBD 4
- ORGO 1
- Target Price
- PSBD $14.13
- ORGO $6.00
- AVG Volume (30 Days)
- PSBD 40.8K
- ORGO 918.0K
- Earning Date
- PSBD 08-07-2025
- ORGO 08-07-2025
- Dividend Yield
- PSBD 12.42%
- ORGO N/A
- EPS Growth
- PSBD N/A
- ORGO N/A
- EPS
- PSBD N/A
- ORGO N/A
- Revenue
- PSBD N/A
- ORGO $458,760,000.00
- Revenue This Year
- PSBD N/A
- ORGO $1.10
- Revenue Next Year
- PSBD N/A
- ORGO $9.93
- P/E Ratio
- PSBD N/A
- ORGO N/A
- Revenue Growth
- PSBD N/A
- ORGO 5.35
- 52 Week Low
- PSBD $11.51
- ORGO $2.28
- 52 Week High
- PSBD $16.85
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- PSBD 52.10
- ORGO 68.34
- Support Level
- PSBD $13.84
- ORGO $3.59
- Resistance Level
- PSBD $14.50
- ORGO $4.70
- Average True Range (ATR)
- PSBD 0.49
- ORGO 0.23
- MACD
- PSBD -0.04
- ORGO 0.12
- Stochastic Oscillator
- PSBD 39.43
- ORGO 81.15
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.